key: cord-0710624-gqtvhtlt
authors: Badani, Ketan K.; Okhawere, Kennedy E.; Chen, Tina; Korn, Talia G.; Razdan, Shirin; Meilika, Kirolos N.; Wilson, Michael P.; Tomy, Tara; Ucpinar, Burak; Kyprianou, Natasha; Dogra, Navneet
title: SARS-CoV-2 RNA Detected in Abdominal Insufflation Samples During Laparoscopic Surgery
date: 2021-10-28
journal: Eur Urol
DOI: 10.1016/j.eururo.2021.10.034
sha: e9f20044d2dd78ccb1571d895bd8f8e15d1a733e
doc_id: 710624
cord_uid: gqtvhtlt

nan

Ketan K. Badani a,b, *, Kennedy E. Okhawere a , Tina Chen c , Talia G. Korn a , Shirin Razdan a , Kirolos N. Meilika a , Michael P. Wilson a , Tara Tomy a , Burak Ucpinar a , Natasha Kyprianou a,b,d , Navneet Dogra c, * Since the emergence of COVID-19, new guidelines have been adopted to protect clinical staff from the potential risk of viral aerosolization during laparoscopy without sufficient data supporting these cautions [1] . Elective procedures have resumed after initial cessation in the USA, and in most institutions a negative SARS-CoV-2 polymerase chain reaction (PCR) assay is required within a few days before scheduled procedures to document the absence of infection. There are scant data on the risks of aerosolization during abdominal laparoscopy to inform guidelines during the COVID-19 pandemic. We sought to evaluate aerosolized plumes from patients undergoing abdominal laparoscopic surgery for the presence of SARS-CoV-2.

Our institutional review board approved this study. Patients undergoing laparoscopic robotassisted nephrectomy or prostatectomy were selected using nonprobabilistic consecutive sampling between September 2020 and January 2021. For all patients, a SARS-CoV-2 PCR test on a nasopharyngeal swab was carried out 2-3 d before surgery. We used a closed-loop insufflation system (AirSeal; CONMED, Largo, FL, USA) in smoke evacuation mode to filter abdominal CO 2 through a 0.01-m ultra-low-particulate air filter. RNA was isolated using an exosomal RNA isolation kit (Norgen Biotex, Thorold, ON, Canada; catalog #58000) and RNA extracts were tested using real-time quantitative PCR (RT-qPCR) for the presence of a SARS-CoV-2 genetic signature. The RT-qPCR procedure uses primers and probes from the US Centers for Disease Control and Prevention 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC, Atlanta, GA, USA; catalog #2019-nCoVEUA-01) and Mastermix from a Promega GoTaq Probe 1-Step RT-qPCR kit (Promega, Madison, WI, USA; catalog #A6120) for detection of SARS-CoV-2. RNA extraction and qPCR were also concomitantly conducted in the same way for negative controls (no template) and positive controls (viral RNA in vitro spike-in using Vero E6 cells).

Of the nine patients (age range 58-78 yr) in the study, two reported a history of COVID-19, but were well beyond the quarantine period deemed acceptable for elective surgery. All patients had negative preoperative PCR results for nasal swabs. The two primer/probe sets (2019-nCoV N1 and N2) were able to detect (cycle threshold [C t ] <40) SARS-CoV-2 in clinical abdominal insufflation samples (Fig. 1) . SARS-CoV-2 was identified via qPCR of the Airseal filter for four of the nine patients (C t 30-40). We detected viral RNA that was differentiated from the negative controls (no template) for the two primer/probe sets (N1 and N2). Four samples exhibited fluorescence growth curves that crossed the threshold within 40 cycles (C t <40) for both the N1 and N2 reactions, thus indicating the presence of viral RNA.

A further two samples exhibited fluorescence growth curves for the N1 primer/probe alone.

Our mock SARS-CoV-2 samples (Fig. 1 , shown in red) confirmed the sensitivity of the primer/probe sets for SARS-CoV-2 detection. The four patients who tested positive for abdominal insufflation samples had either prior COVID-19 (n = 2) or high-risk exposure (n = 2) in the months before their surgery.

Viral particles have previously been detected in surgical smoke [2] ; however, the theoretical risk of propagation of SARS-CoV-2 particles from pneumoperitoneum has not been reported.

Our positive SARS-CoV-2 PCR results for four out of nine patients, despite negative preoperative swab results, represent the first documented finding of SARS-CoV-2 in pneumoperitoneum during laparoscopic surgery. Hypotheses that may explain the discordance between preoperative and intra-abdominal PCR findings include false-negative preoperative tests and a history of prior infection or exposure to the virus with persistent intra-abdominal viral shedding. These phenomena have been demonstrated in previous studies [3, 4] . Although our study is limited by its small sample size, the results show that SARS-CoV-2 can be isolated from pneumoperitoneum. However, the risk of active viral shedding and the potential risk of transmission were not evaluated and will require further investigation.

The authors have nothing to disclose.

Funding: This study was supported by CONMED. The sponsor played a role in collection of the data.

Safe management of surgical smoke in the age of COVID-19

Society of American Gastroenterology and Endoscopic Surgeons. SAGES and EAES recommendations regarding surgical response to COVID-19 crisis

Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT?

Persistent viral shedding of SARS-CoV-2 in faeces -a rapid review

1 -SARS-CoV-2 quantitative polymerase chain reaction (PCR) assay for abdominal insufflation samples from patients undergoing laparoscopic surgery. Patients 4, 5, 6, and 9 showed positive PCR results for SARS-CoV-2, all of whom had negative

We are grateful to the patients who agreed to participate in this study to help advance our research.

Primer/probe set Cycle threshold